Antimicrobial use and resistance in Africa

Antimicrobial Resistance in Developing Countries

Volumn 9780387893709, Issue , 2010, Pages 301-314

  Okeke, Iruka N ^a   Ojo, Kayode K ^b  

^a HAVERFORD COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78049363907     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-89370-9_17     Document Type: Chapter

References (77)

1. Aarestrup, F. M., Seyfarth, A. M., Emborg, H. D., Pedersen, K., Hendriksen, R. S., and Bager, F. (2001). Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother, 45, 2054-2059.
2. Addy, P. A. (1994). Susceptibility pattern of Neisseria gonorrhoeae isolated at the Komfo, Anokye Teaching Hospital, Ghana to commonly prescribed antimicrobial agents. East Afr Med J, 71, 368-372.
3. Agyepong, I. A., Ansah, E., Gyapong, M., Adjei, S., Barnish, G., and Evans, D. (2002). Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana. Soc Sci Med, 55, 2215-2226.
4. Amexo, M., Tolhurst, R., Barnish, G., and Bates, I. (2004). Malaria misdiagnosis: effects on the poor and vulnerable. Lancet, 364, 1896-1898.
5. Amin, A. A., Snow, R. W., and Kokwaro, G. O. (2005). The quality of sulphadoxinepyrimethamine and amodiaquine products in the Kenyan retail sector. J Clin Pharm Ther, 30, 559-565.
6. Arrow, K., Panosian, C., and Gelband, H. (2004). Saving lives, buying time. Economics of malaria drugs in an age of resistance. The National Academies Press, Washington, DC.
7. Babalola, O., and Lamikanra, A. (2002). Pattern of antibiotic purchases in community pharmacies in South Western Nigeria. J Soc Admin Pharm, 19, 33-38.
8. Basco, L. K. (2004). Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. Am J Trop Med Hyg, 70, 245-250.
9. Bergstrom, C. T., Lo, M., and Lipsitch, M. (2004). Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A, 101, 13285-13290.
10. Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P., Njenga, S., Hart, C. A., Maitland, K., English, M., Marsh, K., and Scott, J. A. (2005). Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med, 352, 39-47.
11. Bexell, A., Lwando, E., von Hofsten, B., Tembo, S., Eriksson, B., and Diwan, V. K. (1996). Improving drug use through continuing education: a randomized controlled trial in Zambia. J Clin Epidemiol, 49, 355-357.
12. Buve, A., Weiss, H. A., Laga, M., Van Dyck, E., Musonda, R., Zekeng, L., Kahindo, M., Anagonou, S., Morison, L., Robinson, N. J., and Hayes, R. J. (2001). The epidemiology of gonorrhoea, chlamydial infection and syphilis in four African cities. AIDS, 15, S79-88.
13. Ceccarelli, D., Salvia, A. M., Sami, J., Cappuccinelli, P., and Colombo, M. M. (2006). New cluster of plasmid-located class 1 integrons in Vibrio cholerae O1 and a dfrA15 cassettecontaining integron in Vibrio parahaemolyticus isolated in Angola. Antimicrob. Agents Chemother., 50, 2493-2499.
14. Chukwuani, C. M., Onifade, M., and Sumonu, K. (2002). Survey of drug use practices and antibiotic prescribing pattern at a general hospital in Nigeria. Pharm World Sci, 24, 188-195.
15. Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D., and White, N. J. (2005). The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med, 2, e100.
16. Colquhoun, J., and Weetch, R. S. (1950). Resistance to chloramphenicol developing during treatment of typhoid fever. Lancet, 2, 621-623.
17. Cooke, F. J., and Wain, J. (2004). The emergence of antibiotic resistance in typhoid fever. Travel Med Infect Dis, 2, 67-74.
18. Coovadia, Y. M., Gathiram, V., Bhamjee, A., Mlisana, K., Pillay, N., Garratt, R. M., Madlalose, T., and Short, M. (1992). The emergence of multi-antibiotic-resistant strains of Salmonella typhi in northern Natal-KwaZulu. S Afr Med J, 81, 280-281.
19. Dalsgaard, A., Forslund, A., Petersen, A., Brown, D. J., Dias, F., Monteiro, S., Molbak, K., Aaby, P., Rodrigues, A., and Sandstrom, A. (2000). Class 1 integron-borne, multipleantibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic Vibrio cholerae O1 strains isolated in Guinea-Bissau. J Clin Microbiol, 38, 3774-3779.
20. Finch, M. J., Morris, J. G., Jr., Kaviti, J., Kagwanja, W., and Levine, M. M. (1988). Epidemiology of antimicrobial resistant cholera in Kenya and East Africa. Am J Trop Med Hyg, 39, 484-490.
21. Gassama, A., Sow, P. S., Fall, F., Camara, P., Gueye-N'diaye, A., Seng, R., Samb, B., M'Boup, S., and Aidara-Kane, A. (2001). Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to human immunodeficiency virus serostatus. Int J Infect Dis, 5, 192-198.
22. Gerbase, A. C., Rowley, J. T., and Mertens, T. E. (1998). Global epidemiology of sexually transmitted diseases. Lancet, 351 Suppl 3, 2-4.
23. Glass, R. I., Huq, M. I., Lee, J. V., Threlfall, E. J., Khan, M. R., Alim, A. R., Rowe, B., and Gross, R. J. (1983). Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh. J Infect Dis, 147, 204-209.
24. Gordon, M. A., Banda, H. T., Gondwe, M., Gordon, S. B., Boeree, M. J., Walsh, A. L., Corkill, J. E., Hart, C. A., Gilks, C. F., and Molyneux, M. E. (2002). Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS, 16, 1633-1641.
25. Graham, S. M., Walsh, A. L., Molyneux, E. M., Phiri, A. J., and Molyneux, M. E. (2000). Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans R Soc Trop Med Hyg, 94, 310-314.
26. Griffith, D. C., Kelly-Hope, L. A., and Miller, M. A. (2006). Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg, 75, 973-977.
27. Gupta, A. (1994). Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach. Pediatr Infect Dis J, 13, 134-140.
28. Haberberger, R. L., Jr., Fox, E., Polycarpe, D., Abbatte, E. A., and Said, S. (1990). Antibiotic susceptibility patterns of Neisseria gonorrhoeae in Djibouti during June 1988. Trans R Soc Trop Med Hyg, 84, 738.
29. Habte-Gabr, E., Geyid, A., and Serdo, D. (1983). Beta-lactamase-producing Neisseria gonorrhoeae in Addis Ababa. Ethiop Med J, 21, 199.
30. Hastings, I. M., Bray, P. G., and Ward, S. A. (2002). Parasitology. A requiem for chloroquine. Science, 298, 74-75.
31. Hastings, I. M., Watkins, W. M., and White, N. J. (2002). The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc Lond B Biol Sci, 357, 505-519.
32. Ivanoff, B., Levine, M. M., and Lambert, P. H. (1994). Vaccination against typhoid fever: present status. Bull World Health Organ, 72, 957-971.
33. Kankwatira, A. M., Mwafulirwa, G. A., and Gordon, M. A. (2004). Non-typhoidal salmonella bacteraemia - an under-recognized feature of AIDS in African adults. Trop Doct, 34, 198-200.
34. Kariuki, S., Mwituria, J., Munyalo, A., Revathi, G., and Onsongo, J. (2004). Typhoid is overreported in Embu and Nairobi, Kenya. Afr J Health Sci, 11, 103-110.
35. Kariuki, S., Revathi, G., Muyodi, J., Mwituria, J., Munyalo, A., Mirza, S., and Hart, C. A. (2004). Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin Microbiol, 42, 1477-1482.
36. Kariuki, S., Revathi, G., Kariuki, N., Muyodi, J., Mwituria, J., Munyalo, A., Kagendo, D., Murungi, L., and Anthony Hart, C. (2005). Increasing prevalence of multidrug-resistant non-typhoidal salmonellae, Kenya, 1994-2003. Int J Antimicrob Agents, 25, 38-43.
37. Kariuki, S., Revathi, G., Kariuki, N., Kiiru, J., Mwituria, J., and Hart, C. A. (2006). Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiol, 6, 101.
38. Kayumba, P. C., Risha, P. G., Shewiyo, D., Msami, A., Masuki, G., Ameye, D., Vergote, G., Ntawukuliryayo, J. D., Remon, J. P., and Vervaet, C. (2004). The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution. J Clin Pharm Ther, 29, 331-338.
39. Kean, B. H. (1979). Chloroquine-resistant falciparum malaria from Africa. JAMA, 241(4), 395.
40. Kublin, J. G., Cortese, J. F., Njunju, E. M., Mukadam, R. A., Wirima, J. J., Kazembe, P. N., Djimde, A. A., Kouriba, B., Taylor, T. E., and Plowe, C. V. (2003). Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis, 187, 1870-1875.
41. Laxminarayan, R. (2004). Act now or later? Economics of malaria resistance. Am J Trop Med Hyg, 71, S187-195.
42. Mason, P. R., and Gwanzura, L. (1988). Characterisation by plasmid profiles, serogroups, and auxotypes of Neisseria gonorrhoeae from Harare, Zimbabwe. Genitourin Med, 64, 303-307.
43. Merrell, D. S., Butler, S. M., Qadri, F., Dolganov, N. A., Alam, A., Cohen, M. B., Calderwood, S. B., Schoolnik, G. K., and Camilli, A. (2002). Host-induced epidemic spread of the cholera bacterium. Nature, 417, 642-645.
44. Mhalu, F. S., Mmari, P. W., and Ijumba, J. (1979). Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet, 1, 345-347.
45. Moodley, P., Moodley, D., and Willem Sturm, A. (2004). Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa. Int J Antimicrob Agents, 24, 192-193.
46. Mullick, S., Watson-Jones, D., Beksinska, M., and Mabey, D. (2005). Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect, 81, 294-302.
47. Mwansa, J. C., Mwaba, J., Lukwesa, C., Bhuiyan, N. A., Ansaruzamman, M., Ramamurthy, T., Alam, M., and Balakrish Nair, G. (2006). Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia. Epidemiol Infect, 135, 847-853.
48. Needham, D. M., Foster, S. D., Tomlinson, G., and Godfrey-Faussett, P. (2001). Socioeconomic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health, 6, 256-259.
49. Nsutebu, E. F., Martins, P., and Adiogo, D. (2003). Prevalence of typhoid fever in febrile patients with symptoms clinically compatible with typhoid fever in Cameroon. Trop Med Int Health, 8, 575-578.
50. Obaseiki-Ebor, E. E., Oyaide, S. M., and Okpere, E. E. (1985). Incidence of penicillinase producing Neisseria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to antibiotics in Benin City, Nigeria. Genitourin Med, 61, 367-370.
51. Okeke, I. N, Lamikanra, A., Czeczulin, J., Dubovsky, F., Kaper, J. B, and Nataro, J. P. (2000). Heterogeneous virulence of enteroaggregative Escherichia coli strains isolated from children in Southwest Nigeria. J Infect Dis, 181, 252-260.
52. Okeke, I. (2007). The microbial rebellion: trends and containment of antimicrobial resistance in Africa. In T. Falola, and M. M. Heaton (Eds.), HIV/AIDS, illness, and African wellbeing. University of Rochester Press. Rochester, NY. pp. 155-181.
53. Okeke, I. N., and Lamikanra, A. (1995). Quality and bioavailability of tetracycline capsules in a Nigerian semi-urban community. Int J Antimicrob Agents, 5, 245-250.
54. Okeke, I. N., and Lamikanra, A. (2001). Quality and bioavailability of ampicillin capsules dispensed in a Nigerian semi-urban community. Afr J Med Med Sci, 30, 47-51.
55. Okeke, I. N., and Lamikanra, A. (2003). Export of antimicrobial drugs by West African travelers. J Travel Med, 10, 133-135.
56. Okeke, I. N., Klugman, K. P., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., and Laxminarayan, R. (2005). Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis, 5, 568-580.
57. Paul, M. O., Aderibigbe, D. A., Sule, C. Z., and Lamikanra, A. (1982). Antimicrobial sensitivity patterns of hospital and non-hospital strains of Staphylococcus aureus isolated from nasal carriers. J Hyg (Cambridge), 89, 253-260.
58. Phillips, R. S. (2001). Current status of malaria and potential for control. Clin Microbiol Rev, 14(1), 208-226.
59. Reyburn, H., Mbatia, R., Drakeley, C., Carneiro, I., Mwakasungula, E., Mwerinde, O., Saganda, K., Shao, J., Kitua, A., Olomi, R., Greenwood, B. M., and Whitty, C. J. (2004). Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ, 329, 1212.
60. Risha, P. G., Shewiyo, D., Msami, A., Masuki, G., Vergote, G., Vervaet, C., and Remon, J. P. (2002). In vitro evaluation of the quality of essential drugs on the Tanzanian market. Trop Med Int Health, 7, 701-707.
61. Schram, R. (1971). A history of the Nigerian health services. Ibadan University Press, Ibadan.
62. Senerwa, D., Olsvik, O., Mutanda, L. N., Lindqvist, K. J., Gathuma, J. M., Fossum, K., and Wachsmuth, K. (1989). Enteropathogenic Escherichia coli serotype O111:HNT isolated from preterm neonates in Nairobi, Kenya. J Clin Microbiol, 27, 1307-1311.
63. Siddique, A. K., Salam, A., Islam, M. S., Akram, K., Majumdar, R. N., Zaman, K., Fronczak, N., and Laston, S. (1995). Why treatment centres failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire. Lancet, 345, 359-361.
64. Singh, J. A., Upshur, R., and Padayatchi, N. (2007). XDR-TB in South Africa: no time for denial or complacency. PLoS Med, 4, e50.
65. Tapsall, J. (2001). Antimicrobial resistance in Neisseria gonorrheae. Geneva, Switzerland: Department of Communicable Disease Surveillance and Response, World Health Organization.
66. Tapsall, J. W. (2005). Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis, 41 Suppl 4, S263-268.
67. Taylor, R. B., Shakoor, O., Behrens, R. H., Everard, M., Low, A. S., Wangboonskul, J., Reid, R. G., and Kolawole, J. A. (2001). Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet, 357, 1933-1936.
68. Thera, M. A., Sehdev, P. S., Coulibaly, D., Traore, K., Garba, M. N., Cissoko, Y., Kone, A., Guindo, A., Dicko, A., Beavogui, A. H., Djimde, A. A., Lyke, K. E., Diallo, D. A., Doumbo, O. K., and Plowe, C. V. (2005). Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis, 192, 1823-1829.
69. Towner, K. J., Pearson, N. J., Mhalu, F. S., and O'Grady, F. (1980). Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull World Health Organ, 58, 747-751.
70. Vila, J., Vargas, M., Casals, C., Urassa, H., Mshinda, H., Schellemberg, D., and Gascon, J. (1999). Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania. Antimicrob Agents Chemother, 43, 3022-3024.
71. Wain, J., and Kidgell, C. (2004). The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever. Trans R Soc Trop Med Hyg, 98, 423-430.
72. West, B., Changalucha, J., Grosskurth, H., Mayaud, P., Gabone, R. M., Ka-Gina, G., and Mabey, D. (1995). Antimicrobial susceptibility, auxotype and plasmid content of Neisseria gonorrhoeae in northern Tanzania: emergence of high level plasmid mediated tetracycline resistance. Genitourin Med, 71, 9-12.
73. WHO (2001). Interventions and strategies to improve the use of antimicrobials in developing countries. World Health Organization, Geneva.
74. Whyte, S. R., Geest, S.v. d., and Hardon, A. (2002). Social lives of medicines Cambridge University Press, Cambridge, UK; New York.
75. Winstanley, P., Ward, S., Snow, R., and Breckenridge, A. (2004). Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Clin Microbiol Rev, 17, 612-637
76. Wolday, D., and Erge, W. (1998). Antimicrobial sensitivity pattern of Salmonella: comparison of isolates from HIV-infected and HIV-uninfected patients. Trop Doct, 28(3), 139-141.
77. Zahra, A. (1956). Yaws eradication campaign in Nsukka division, Eastern Nigeria. A preliminary review. Bull World Health Organ, 15, 911-915.